Found: 12
Select item for more details and to access through your institution.
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.
- Published in:
- Rheumatology, 2014, v. 53, n. 3, p. 502, doi. 10.1093/rheumatology/ket378
- By:
- Publication type:
- Article
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up.
- Published in:
- Rheumatology, 2013, v. 52, n. 7, p. 1313, doi. 10.1093/rheumatology/ket129
- By:
- Publication type:
- Article
Rheumatoid arthritis disease measurement: a new old idea.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Rheumatoid arthritis disease measurement: a new old idea.
- Published in:
- Rheumatology, 2012, v. 51, n. suppl_6, p. vi21, doi. 10.1093/rheumatology/kes282
- By:
- Publication type:
- Article
Allosteric Tuning of Caspase‐7: Establishing the Nexus of Structure and Catalytic Power.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 40, p. 1, doi. 10.1002/chem.202300872
- By:
- Publication type:
- Article
Front Cover: Allosteric Tuning of Caspase‐7: Establishing the Nexus of Structure and Catalytic Power (Chem. Eur. J. 40/2023).
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 40, p. 1, doi. 10.1002/chem.202301620
- By:
- Publication type:
- Article
Allosteric Tuning of Caspase‐7: Establishing the Nexus of Structure and Catalytic Power.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 40, p. 1, doi. 10.1002/chem.202300872
- By:
- Publication type:
- Article
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 2, p. 362, doi. 10.1002/art.39856
- By:
- Publication type:
- Article
Decrypting a cryptic allosteric pocket in H. pylori glutamate racemase.
- Published in:
- Communications Chemistry, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42004-021-00605-z
- By:
- Publication type:
- Article
Therapeutic disruption of RAD52--ssDNA complexation via novel drug-like inhibitors.
- Published in:
- NAR Cancer, 2023, v. 5, n. 2, p. 1, doi. 10.1093/narcan/zcad018
- By:
- Publication type:
- Article
Genetic Interactions With CLF1 Identify Additional Pre-mRNA Splicing Factors and a Link Between Activators of Yeast Vesicular Transport and Splicing.
- Published in:
- Genetics, 2003, v. 164, n. 3, p. 895, doi. 10.1093/genetics/164.3.895
- By:
- Publication type:
- Article